Literature DB >> 19015168

Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how?

Masakazu Haneda, Akizuki Morikawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19015168     DOI: 10.1093/ndt/gfn616

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  10 in total

Review 1.  Haemodialysis-induced hypoglycaemia and glycaemic disarrays.

Authors:  Masanori Abe; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2015-04-07       Impact factor: 28.314

Review 2.  Diabetes treatment in patients with renal disease: Is the landscape clear enough?

Authors:  Ioannis Ioannidis
Journal:  World J Diabetes       Date:  2014-10-15

Review 3.  Pharmacokinetics and clinical use of incretin-based therapies in patients with chronic kidney disease and type 2 diabetes.

Authors:  André J Scheen
Journal:  Clin Pharmacokinet       Date:  2015-01       Impact factor: 6.447

4.  Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus.

Authors:  György Jermendy; István Wittmann; László Nagy; Zoltán Kiss; György Rokszin; Zsolt Abonyi-Tóth; Lajos Katona; György Paragh; István Karádi; Béla Merkely
Journal:  Med Sci Monit       Date:  2012-02

5.  Survey of Hypoglycemia in Elderly People With Type 2 Diabetes Mellitus in Japan.

Authors:  Masahiro Fukuda; Kunihiro Doi; Masahiro Sugawara; Yoshikazu Naka; Kouichi Mochizuki
Journal:  J Clin Med Res       Date:  2015-10-23

6.  Secular Trends in the Clinical Characteristics of Type 2 Diabetic Patients With Severe Hypoglycemia Between 2008 and 2013.

Authors:  Hiroyuki Ito; Emiko Tsugami; Shigenori Ando; Ayano Imai; Suzuko Matsumoto; Takashi Omoto; Masahiro Shinozaki; Shinya Nishio; Mariko Abe; Shinichi Antoku; Mizuo Mifune; Michiko Togane
Journal:  J Clin Med Res       Date:  2016-08-30

7.  Has the safety of diabetes therapy improved? Lessons from an analysis of diabetic medication-induced severe hypoglycemic cases in an emergency department from 2005 to 2013.

Authors:  Akizuki Morikawa; Yuko Morikawa; Masahiro Nomura; Jun Watanabe; Hiroya Kitsunai; Masakazu Haneda
Journal:  Diabetol Int       Date:  2015-12-08

8.  Pharmacokinetic and pharmacodynamic profiles of canagliflozin in Japanese patients with type 2 diabetes mellitus and moderate renal impairment.

Authors:  Nobuya Inagaki; Kazuoki Kondo; Toru Yoshinari; Manabu Ishii; Masaki Sakai; Hideki Kuki; Kenichi Furihata
Journal:  Clin Drug Investig       Date:  2014-10       Impact factor: 2.859

9.  Efficacy and safety of saxagliptin as add-on therapy in type 2 diabetes.

Authors:  Joshua J Neumiller
Journal:  Clin Diabetes       Date:  2014-10

10.  Effects of Repaglinide Versus Glimepiride on 1,5-Anhydroglucutol and Glycated Hemoglobin Levels in Japanese Patients With Type 2 Diabetes.

Authors:  Hodaka Yamada; Masafumi Kakei; Kazuo Hara
Journal:  J Clin Med Res       Date:  2018-10-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.